Trump: COVID-19 vaccine to be delayed to N.Y. due to restrictions
President Trump made his first public remarks since falsely claiming he won the election.
Vaccine
Biden wins in Georgia, CBS News projects
CBS News projects President-elect Joe Biden will carry the state of Georgia, matching President Trump’s 2016 Electoral College win. Mr. Trump is projected to take North Carolina. The president offered a rosy outlook on a coronavirus vaccine during an address in the Rose Garden Friday, his first address since the presidential race was called for Mr. Biden. Paula Reid shares some of what he said.
COVID-19 cases surge: The latest perspective
COVID-19 cases are surging. CBS News medical contributor Dr. David Agus looks at the rise in cases, the upcoming holidays and the latest with vaccines.
Operation Warp Speed and foreign talent
According to Emergent BioSolution’s Sean Kirk, whose company is rushing to produce several anticipated COVID-19 vaccines, the government is helping obtain visas for foreign expertise.
COVID-19 vaccine: the $12 billion gamble
Emergent BioSolution’s Sean Kirk, whose company is manufacturing several anticipated COVID-19 vaccines, says the rush to manufacture vaccines without FDA approval is a worthy financial risk
COVID-19 vaccine: The taxpayers' gamble
In the race to create a coronavirus vaccine through Operation Warp Speed, companies are manufacturing vaccines before getting FDA approval. It's a financial risk they hope pays.
How COVID vaccines are bulk manufactured
With $628 million from the U.S. government, Emergent Bio-Solutions in Baltimore is scaling up separate Johnson & Johnson and AstraZeneca COVID-19 vaccines, which are still pending FDA approval.
How COVID vaccines are bulk manufactured
With $628 million from the U.S. government, Emergent BioSolutions in Baltimore is scaling up separate Johnson & Johnson and AstraZeneca COVID-19 vaccines, which are still pending FDA approval.
State of White House COVID-19 task force
Sources tell CBS News President Trump has not attended a White House Coronavirus Task Force meeting in months. It comes as cases, hospitalizations, and deaths from the virus surge nationwide. CBS News White House correspondent Paula Reid joined "CBSN AM" with the latest.
Russia says vaccine 92% effective as 4 doctors who got it catch COVID
At least 4 Russian health workers given the country's 1st coronavirus vaccine have caught the disease, but officials say it just didn't have enough time to work.
New U.S. record for COVID-19 hospitalizations
Dr. Neeta Ogden, an internal medicine specialist and immunologist, joined CBSN to discuss the surge in COVID-19 cases in the U.S. and how it's impacting hospitals across the nation. She also discussed a new analysis by Fair Health claiming people with intellectual and developmental challenges are three times more likely to die of the coronavirus compared with patients without those conditions.
Pfizer gearing up to distribute COVID-19 vaccine
"My biggest fear is that we're dealing with a surge at the same time that we're trying to vaccinate," said New Jersey Health Commissioner Judith Persichilli.
Pfizer official talks COVID-19 vaccine
Pfizer chief scientific officer Dr. Mikael Dolsten spoke with CBS News' Dr. Jon LaPook after the drugmaker announced that human trials suggest its coronavirus vaccine is more than 90% effective.
11/10/20: Red and Blue
AG Barr allows prosecutors to probe voter fraud; Sydney Barber makes history at U.S. Naval Academy
Biden welcomes progress on COVID vaccine
President-elect Joe Biden is welcoming the progress being made toward a coronavirus vaccine, but said the process must be transparent to ensure confidence and safety. Bina Venkataraman, an editorial page editor for the Boston Globe and former adviser to President Obama's Council of Advisors on Science and Technology during the Ebola pandemic, spoke to CBSN's "Red & Blue" host Elaine Quijano about the efforts to ensure public trust in a coronavirus vaccine.
Alex Azar on Pfizer vaccine announcement
Secretary of Health and Human Services Alex Azar joins "CBS This Morning" following drug maker Pfizer's announcement that its coronavirus vaccine is 90% effective. Azar discusses his hope for the vaccine, how the government will distribute it and how the White House will transition to a Biden administration in January.
Markets soar on Pfizer vaccine, election news
Stock markets got a shot in the arm after promising news of a vaccine and election results were announced. CBS News business analyst Jill Schlesinger explains the factors behind the market surge.
New hope for a COVID-19 vaccine
Pfizer says its new coronavirus vaccine has proven to be more than 90% effective, and it could be used before the end of the year. Dr. Jon LaPook reports.
Horseshoe crabs help keep vaccines safe but are in big trouble
The ancient create is facing possible extinction. Its blood is used to help keep vaccines and IV medicines free of contamination.
Two more members of Trump's team test positive for COVID-19
Housing and Urban Development Secretary Ben Carson tested positive for COVID-19 on Monday after attending a White House election night party last week. Mark Meadows, who also attended that party, tested positive last week. The man leading President Trump's post-election legal fight, attorney David Bossie, also revealed his positive diagnosis Monday. Dr. Dara Kass, an emergency room physician and a member of the group Doctors for Biden, spoke to CBSN's "Red & Blue" host Elaine Quijano about the promising news from Pfizer's vaccine trial and the crucial period the U.S. is entering in its efforts to contain the virus.
Pfizer says COVID-19 vaccine is over 90% effective
Drugmaker Pfizer said trials show its vaccine is 90% effective in preventing coronavirus infections, and it could apply for emergency use authorization within weeks. Dr. Jon LaPook has details.
Doctor on Pfizer's COVID-19 vaccine
Emergency care physician Dr. Ron Elfenbein joined CBSN to discuss the latest announcement by Pfizer about its coronavirus vaccine. The company says testing shows its vaccine may be 90% effective.
Pfizer says trials show its COVID vaccine "more than 90% effective"
"We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis," Pfizer CEO says.
Pfizer says its COVID vaccine is 90% effective
U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already. Dr. David Agus joins "CBS This Morning" to discuss what this means and what is expected to happen next.
Stay-at-home stocks hammered on positive vaccine news
Pfizer results prompt investors to sell companies like Zoom, Peloton and Netflix that had profited from pandemic lockdowns.
3 children, 1 teacher killed in Oregon school shooting, police say
Vance says "selling access to the White House" is "disgusting"
White House prepares plans to use "mother of all bombs" on Iran
Exclusive
Ousted general warned of missile defense shortage before Iran war
Live
Strait of Hormuz still unsafe for ships, maritime group warns
Trump calls off plan to livestream Fort Hood shooter's execution
White House's Katie Zacharia confirms she never passed bar exam
Sikh separatist says FBI warned him of new threat against him
